NCT04099823 MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
| NCT ID | NCT04099823 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Hydrocephalus |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2019-10-31 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2019-10-31 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Researchers are trying to test a MR imaging method for detection of Cerebral Spinal Fluid (CSF) flow in the brain to help diagnosis and better understand diseases that affect brain function.
Eligibility Criteria
Inclusion Criteria: * A healthy control will be defined as an otherwise healthy person who does not have a medical condition that affects brain function or have problems with concentration, memory, balance, or coordination. * Patients who have a suspected diagnosis of altered CSF dynamics including but not limited to normal pressure hydrocephalus will be referred to Dr. Cogswell by their care team to be included in the study. Conditions of altered CSF dynamics include obstructive and non-obstructive hydrocephalus and may be associated with headaches and/or decreased cognitive function. * Similarly, patients with impaired cognitive function including but not limited to Alzheimer's disease will be referred to Dr. Cogswell by their care team to be included in the study. Exclusion Criteria: * Subjects with non-MRI compatible devices * required sedation * women who may be pregnant will be excluded. * The first 10 subjects with normal pressure hydrocephalus will not have previously been shunted.
Contact & Investigator
Petrice Cogswell, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT04099823 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hydrocephalus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04099823 currently recruiting?
Yes, NCT04099823 is actively recruiting participants. Contact the research team at Walsh.Suson@mayo.edu for enrollment information.
Where is the NCT04099823 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT04099823 clinical trial?
NCT04099823 is sponsored by Mayo Clinic. The principal investigator is Petrice Cogswell, MD at Mayo Clinic. The trial plans to enroll 50 participants.